scispace - formally typeset
B

Benedikt Weissbrich

Researcher at University of Würzburg

Publications -  77
Citations -  3168

Benedikt Weissbrich is an academic researcher from University of Würzburg. The author has contributed to research in topics: Virus & Medicine. The author has an hindex of 32, co-authored 66 publications receiving 2939 citations.

Papers
More filters
Journal ArticleDOI

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

TL;DR: Subtypes of GBS defined by preceding infections were only approximately associated with different patterns of clinical, neurophysiologic, and immunologic features, implying interaction with additional host factors.
Journal ArticleDOI

Molecular Typing of Enteroviruses: Current Status and Future Requirements

TL;DR: The case for developing a molecular typing system is argued, the genetic basis of such a system is discussed, the literature describing attempts to identify or classify enteroviruses by molecular methods is reviewed, and ways in which the goal of molecular typing may be realized are suggested.
Journal ArticleDOI

Frequent detection of bocavirus DNA in German children with respiratory tract infections

TL;DR: HBoV is frequently found in NPAs of hospitalized infants and children with acute respiratory tract diseases, and application of some of Koch's revised postulates is not possible because of the high rate of coinfections with hBoV and other respiratory tract pathogens.
Journal ArticleDOI

Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection

TL;DR: The studies show that CMV is a particularly active inducer of some, but not all, members of the herpes virus family and suggest that the in vivo interplay between CMV and EBV occurs unidirectionally, and the high frequency of heterologous herpes virus immunoreactivations poses demands on laboratory diagnosis.
Journal ArticleDOI

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study

TL;DR: It is demonstrated clearly that citalopram treatment is highly effective in HCV patients on interferon therapy, when initiated after the onset of clinically relevant depressive symptoms, which suggests that a general SSRI prophylaxis is not necessary in these patients.